607 related articles for article (PubMed ID: 11391710)
1. In vitro exposure to hydroxyurea reduces sickle red blood cell deformability.
Huang Z; Louderback JG; King SB; Ballas SK; Kim-Shapiro DB
Am J Hematol; 2001 Jul; 67(3):151-6. PubMed ID: 11391710
[TBL] [Abstract][Full Text] [Related]
2. Effect of hydroxyurea on the rheological properties of sickle erythrocytes in vivo.
Ballas SK; Dover GJ; Charache S
Am J Hematol; 1989 Oct; 32(2):104-11. PubMed ID: 2757007
[TBL] [Abstract][Full Text] [Related]
3. Influence of pH on the rheologic and antisickling effects of dimethyl adipimidate.
Pennathur-Das R; Lande WM; Mentzer WC; Mohandas N; Preisler H; Kleman KM; Heath RH; Lubin BH
J Lab Clin Med; 1984 Nov; 104(5):718-29. PubMed ID: 6491469
[TBL] [Abstract][Full Text] [Related]
4. Time resolved absorption study of the reaction of hydroxyurea with sickle cell hemoglobin.
Kim-Shapiro DB; King SB; Bonifant CL; Kolibash CP; Ballas SK
Biochim Biophys Acta; 1998 Mar; 1380(1):64-74. PubMed ID: 9545536
[TBL] [Abstract][Full Text] [Related]
5. Rheological properties of sickle erythrocytes in patients with sickle-cell anemia: The effect of hydroxyurea, fetal hemoglobin, and α-thalassemia.
Ballas SK; Connes P;
Eur J Haematol; 2018 Dec; 101(6):798-803. PubMed ID: 30204261
[TBL] [Abstract][Full Text] [Related]
6. New insights provided by a comparison of impaired deformability with erythrocyte oxidative stress for sickle cell disease.
Barodka VM; Nagababu E; Mohanty JG; Nyhan D; Berkowitz DE; Rifkind JM; Strouse JJ
Blood Cells Mol Dis; 2014 Apr; 52(4):230-5. PubMed ID: 24246527
[TBL] [Abstract][Full Text] [Related]
7. Influence of sickle hemoglobin polymerization and membrane properties on deformability of sickle erythrocytes in the microcirculation.
Dong C; Chadwick RS; Schechter AN
Biophys J; 1992 Sep; 63(3):774-83. PubMed ID: 1420913
[TBL] [Abstract][Full Text] [Related]
8. Effect of hydroxyurea on the deformability of the red blood cell membrane in patients with sickle cell anemia.
Athanassiou G; Moutzouri A; Kourakli A; Zoumbos N
Clin Hemorheol Microcirc; 2006; 35(1-2):291-5. PubMed ID: 16899945
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyurea therapy modulates sickle cell anemia red blood cell physiology: Impact on RBC deformability, oxidative stress, nitrite levels and nitric oxide synthase signalling pathway.
Nader E; Grau M; Fort R; Collins B; Cannas G; Gauthier A; Walpurgis K; Martin C; Bloch W; Poutrel S; Hot A; Renoux C; Thevis M; Joly P; Romana M; Guillot N; Connes P
Nitric Oxide; 2018 Dec; 81():28-35. PubMed ID: 30342855
[TBL] [Abstract][Full Text] [Related]
10. Pharmaco-proteomic study of hydroxyurea-induced modifications in the sickle red blood cell membrane proteome.
Ghatpande SS; Choudhary PK; Quinn CT; Goodman SR
Exp Biol Med (Maywood); 2008 Dec; 233(12):1510-7. PubMed ID: 18849548
[TBL] [Abstract][Full Text] [Related]
11. Effects of hydroxyurea and L-arginine on the production of nitric oxide metabolites in cultures of normal and sickle erythrocytes.
Nahavandi M; Tavakkoli F; Millis RM; Wyche MQ; Habib MJ; Tavakoli N
Hematology; 2006 Aug; 11(4):291-4. PubMed ID: 17178670
[TBL] [Abstract][Full Text] [Related]
12. Static and dynamic rigidities of normal and sickle erythrocytes. Major influence of cell hemoglobin concentration.
Evans E; Mohandas N; Leung A
J Clin Invest; 1984 Feb; 73(2):477-88. PubMed ID: 6699172
[TBL] [Abstract][Full Text] [Related]
13. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
Covas DT; de Lucena Angulo I; Vianna Bonini Palma P; Zago MA
Haematologica; 2004 Mar; 89(3):273-80. PubMed ID: 15020264
[TBL] [Abstract][Full Text] [Related]
14. Measurements of red cell deformability and hydration reflect HbF and HbA
Parrow NL; Tu H; Nichols J; Violet PC; Pittman CA; Fitzhugh C; Fleming RE; Mohandas N; Tisdale JF; Levine M
Blood Cells Mol Dis; 2017 Jun; 65():41-50. PubMed ID: 28472705
[TBL] [Abstract][Full Text] [Related]
15. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea.
Rodgers GP; Dover GJ; Noguchi CT; Schechter AN; Nienhuis AW
N Engl J Med; 1990 Apr; 322(15):1037-45. PubMed ID: 1690857
[TBL] [Abstract][Full Text] [Related]
16. Treatment of sickle cell anemia with hydroxyurea and erythropoietin.
Goldberg MA; Brugnara C; Dover GJ; Schapira L; Charache S; Bunn HF
N Engl J Med; 1990 Aug; 323(6):366-72. PubMed ID: 1695325
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia.
Lemonne N; Charlot K; Waltz X; Ballas SK; Lamarre Y; Lee K; Hierso R; Connes C; Etienne-Julan M; Romana M; Connes P
Haematologica; 2015 Oct; 100(10):e383-6. PubMed ID: 26137960
[No Abstract] [Full Text] [Related]
18. Oxpentifylline and cetiedil citrate improve deformability of dehydrated sickle cells.
Stuart J; Stone PC; Bilto YY; Keidan AJ
J Clin Pathol; 1987 Oct; 40(10):1182-6. PubMed ID: 3119675
[TBL] [Abstract][Full Text] [Related]
19. Effect of hydrogen peroxide exposure on normal human erythrocyte deformability, morphology, surface characteristics, and spectrin-hemoglobin cross-linking.
Snyder LM; Fortier NL; Trainor J; Jacobs J; Leb L; Lubin B; Chiu D; Shohet S; Mohandas N
J Clin Invest; 1985 Nov; 76(5):1971-7. PubMed ID: 4056060
[TBL] [Abstract][Full Text] [Related]
20. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]